2013
DOI: 10.1002/bdd.1862
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and safety of the sesame lignans, sesamin and episesamin, in healthy subjects

Abstract: A single-blind, placebo-controlled, parallel-group and multiple oral dose study was conducted in 48 healthy subjects to investigate the pharmacokinetics and safety of multiple oral doses of sesame lignans (sesamin and episesamin). Subjects were randomly divided into two groups. Each subject was administered 50 mg of sesame lignans (sesamin/episesamin=1/1) or placebo once daily for 28 days. The pharmacokinetics of the sesame lignans were investigated using 10 of the 24 subjects in the sesame lignans group. No s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(38 citation statements)
references
References 32 publications
(40 reference statements)
1
34
0
Order By: Relevance
“…e administration of sesamin alleviated blood-brain barrier disruption in mice with traumatic brain injury and reduced the size of brain infarct in ischemic mice [23]. Additionally, the pharmacokinetics of sesamin in humans showed that sesamin was detected in blood at 5 h after ingestion and cleared from the body within 24 h. ese data confirmed the safety of sesamin use in humans [24]. From these reports, sesamin has become an interesting phytochemical compound for neurodegenerative disease treatment.…”
Section: Discussionmentioning
confidence: 74%
“…e administration of sesamin alleviated blood-brain barrier disruption in mice with traumatic brain injury and reduced the size of brain infarct in ischemic mice [23]. Additionally, the pharmacokinetics of sesamin in humans showed that sesamin was detected in blood at 5 h after ingestion and cleared from the body within 24 h. ese data confirmed the safety of sesamin use in humans [24]. From these reports, sesamin has become an interesting phytochemical compound for neurodegenerative disease treatment.…”
Section: Discussionmentioning
confidence: 74%
“…Sesamin and SC‐1 were measured by ultraperformance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) as previously described (Tomimori et al . ).…”
Section: Methodsmentioning
confidence: 97%
“…Plasma samples were extracted after hydrolysis with ÎČ-glucuronidase/arylsulfatase. Sesamin and SC-1 were measured by ultraperformance liquid chromatographytandem mass spectrometry (UPLC-MS/MS) as previously described (Tomimori et al 2013).…”
Section: Plasma Concentrations Of Sesamin and Sc-1mentioning
confidence: 99%
“…The conversion of sesamin into catechol derivatives and converted further into glucuronides or sulfates in the liver [70][71][72][73] has been reported to have anti-inflammatory effect on macrophage cell line (J774.1 cells). The said sesamin metabolites have been reported to have strong inhibitory effects on the LPS-induced NO production [74].…”
Section: Liver Diseasementioning
confidence: 99%